What Tesamorelin is
Tesamorelin is a synthetic version of growth hormone-releasing hormone (GHRH). It signals the pituitary to release more of the body's own growth hormone. It is in the same family as CJC-1295, but unlike CJC-1295, it went through full FDA review.
It is popular online for belly fat loss. Its approval covers a much narrower use than that.
Approved March 2025, replacing Egrifta SV. Reconstituted weekly, injected daily. Reduces excess abdominal fat in adults with HIV-associated lipodystrophy.
Earlier version, being phased out. Not interchangeable with WR because strength, mixing, and storage differ.
Regulatory status in 2026
Tesamorelin is approved only as Egrifta, for one condition. Because an approved product exists, compounding it is restricted.
Tesamorelin first approved as Egrifta for HIV-associated lipodystrophy.
Egrifta SV approved.
Egrifta WR approved as the replacement for SV.
Approved for one use only. Compounded tesamorelin is restricted. Prohibited in sport at all times under WADA class S2.
Regulatory status can change. Check the sources linked at the bottom of this page before relying on anything here.
What's proven vs. what's claimed
Tesamorelin has solid trial data for its approved use. Most online claims extend it to people that use was never tested in.
Reduces belly (visceral) fat in HIV lipodystrophy.
Shown in randomized trials. This is the approved use.
Strong human evidenceMelts belly fat in anyone.
Not established outside the approved population.
Insufficient dataBuilds muscle and slows aging.
Not shown.
Insufficient dataStorage and stability
Egrifta WR and Egrifta SV have different storage instructions. Follow the carton and pharmacist for your version.
Egrifta (brand)
- Store exactly as the carton for your version says.
- WR and SV are not interchangeable, including in how they're stored and mixed.
- Keep vials in the carton to protect from light.
Gray-market tesamorelin
- Keep refrigerated. Do not freeze.
- Protect from light. Clear glass lets it through.
- Opened multi-dose bacteriostatic water is typically discarded 28 days after first puncture.
- Log the mix date so you know the vial's age at a glance.
Light exposure is easy to overlook in a fridge door that opens dozens of times a day. VIALTIGHT is building stackable cases that block light from every side. See vialtight.com for updates.
Safety flags
Not for some people. The label says not to use it during pregnancy, with an active cancer, or with certain pituitary conditions.
Blood sugar and IGF-1. It can raise blood sugar and IGF-1. The label calls for monitoring.
Common side effects. Joint pain, injection site reactions, swelling, and muscle pain were reported in trials.
Tested athletes. Prohibited at all times under WADA class S2.
FAQ
Is tesamorelin the same as CJC-1295?
No. Both act like GHRH, but tesamorelin is a different molecule with FDA approval. CJC-1295 has none.
Can I get compounded tesamorelin?
Generally no. Because an approved product exists and is available, compounding is restricted.
Does VialTracker tell me what to take?
No. VialTracker organizes the information you enter and runs the math. It does not recommend doses, products, or protocols.